• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

March 30, 2001

View Archived Issues

Schering AG provides update at annual press conference

Read More

Encouraging preclinical results reported for Titan's controlled-release buprenorphine

Read More

NVP-DPP-728 improves glucose tolerance in rat model

Read More

Schering AG's liver-specific contrast agent approved in Sweden

Read More

NeoPharm files IND for liposomal mitoxantrone

Read More

Yamanouchi and Pharmacia amend celecoxib agreement for Japan

Read More

New vaccine targets for cancer-causing strains of HPV identified

Read More

Oxeze Turbuhaler approved in Canada for control and relief of asthma symptoms

Read More

NPS and AstraZeneca join forces in drug development alliance

Read More

Dainippon's AR inhibitor improves diabetic neuropathy in laboratory study

Read More

Phase I/II evaluation of Titan's Pivanex begins in liver cancer

Read More

CPMP issues positive opinion for Fabrazyme

Read More

Micafungin heading for regulatory filings this year and next

Read More

PG-TXL proves superior to free paclitaxel against human colon cancer xenografts

Read More

AACR presentation points to potential new indication for ABX-IL-8: melanoma

Read More

AACR news: preliminary phase I/II results with Vaxid indicate good safety, immunogenicity

Read More

PEG-Intron/Rebetol combination for hepatitis C treatment approved in E.U.

Read More

Voluntary withdrawal of injectable anesthesia drug by Organon

Read More

Tumstatin exerts antiangiogenic and apoptotic effects according to preclinical studies

Read More

Drotrecogin alfa (activated) granted FDA priority review for severe sepsis

Read More

European approval granted for Sanofi-Synthelabo's Fasturtec

Read More

Pyrrolidine-based influenza neuraminidase inhibitors under study at Abbott

Read More

Potent and selective MC4 receptor antagonists useful for weight and pigmentation disorders

Read More

Japanese researchers describe potential new therapy for diastolic heart failure

Read More

Hydroxamic acid-based MMP inhibitors disclosed by Novartis

Read More

BASF presents new vitronectin inhibitors and possible uses thereof

Read More

Potassium channel blockers targeting the slow delayed rectifier designed by Merck

Read More

Glycine-site NMDA receptor antagonists discovered at Gruenenthal

Read More

New erythromycin derivatives from Taisho exert potent antibacterial activity

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe